Oligodendrocytes are the predominant cell type in white matter and are highly vulnerable to ischemic injury. The role of oligodendrocyte dysfunction in ischemic brain injury is unknown. In this study, we used a 24-amino acid peptide S14G-Humanin (HNG) to examine oligodendrogenesis and neurological functional recovery in a hypoxic/ischemic (H/I) neonatal model. Intraperitoneal HNG pre-treatment decreased infarct volume following H/I injury. Delayed HNG treatment 24 h after H/I injury did not reduce infarct volume but did decrease neurological deficits and brain atrophy. Delayed HNG treatment did not attenuate axonal demyelination at 48 h after H/I injury. However, at 14 d after H/I injury, delayed HNG treatment increased axonal remyelination, the thickness of corpus callosum at the midline, the number of Olig2(+) /BrdU(+) cells, and levels of brain-derived neurotrophic factor (BDNF). Our results suggest that targeting oligodendrogenesis via delayed HNG treatment may represent a promising approach for the treatment of stroke.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/hipo.22350 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Poststroke hyperglycemia dysregulates cap-dependent translation in neural cells.
Life Sci
January 2025
Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Neuroscience, School of Medicine, and Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States; Department of Pharmaceutical Sciences, School of Pharmacy, Morgantown, WV, United States; Department of Anesthesiology and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, United States. Electronic address:
Aims: Post stroke hyperglycemia has been shown to deter functional recovery. Earlier findings have indicated the cap-dependent translation regulator 4E-BP1 is detrimentally upregulated in hyperglycemic conditions. The present study aims to test the hypothesis that hyperglycemic ischemic reperfusion injury (I/R) affects normal protein translation poststroke.
View Article and Find Full Text PDFGalectin-1 Induces the Production of Immune-Suppressive Cytokines in Human and Mouse T Cells.
Int J Mol Sci
November 2024
Galecto Biotech AB, Cobis Science Park, Ole Maaloes Vej 3, DK-2200 Copenhagen, Denmark.
Galectin-1 is implicated in several pro-tumourigenic mechanisms and is considered immune-suppressive. The pharmacological inhibition of galectin-1 may be beneficial in cancers in which galectin-1 is overexpressed and driving cancer progression. This study aimed to further characterise the immunosuppressive cytokines influenced by galectin-1 in in vitro immune cell cultures and an in vivo inflammatory model using a recently discovered selective inhibitor of galectin-1, GB1908.
View Article and Find Full Text PDFInfluence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113.
Int J Clin Oncol
January 2025
Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
Article Synopsis
- Major hepatectomy (MH) can lead to a higher risk of adverse events due to reduced liver function and surgical impact, prompting an analysis within the JCOG1113 trial focused on gemcitabine-based treatments for advanced biliary tract cancer.* -
- Among 354 patients, 76 were evaluated post-surgery for recurrence; results indicated that while platelet counts fell more in patients who underwent MH, anemia and white blood cell count decreases were less frequent compared to those who did not have MH.* -
- Overall survival rates were similar between MH and non-MH patients receiving gemcitabine with both S-1 and cisplatin, suggesting that gemcitabine-based chemotherapy maintains its safety and efficacy
Absence of Kidney Tubular Injury in Patients With Acute Heart Failure With Acute Kidney Injury.
Circ Heart Fail
November 2024
School of Medicine, University College Dublin, Ireland (S.D., R.I., J.M.C., P.T.M.).
Background: Worsening renal function (WRF) is common in hospitalized patients being treated for acute heart failure. However, discriminating clinically significant WRF remains challenging. In patients hospitalized with acute heart failure, we evaluated if blood and urine biomarkers of cardiac and kidney dysfunction were associated with adverse outcomes.
View Article and Find Full Text PDFIncidence and Outcomes of Patients With Early Cardiac Complications After Intracerebral Hemorrhage: A Report From VISTA.
Stroke
November 2024
Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, United Kingdom (H.I., B.H., W.K.E.-B., G.Y.H.L., A.H.A.-R.).
Article Synopsis
- The study examines early cardiac complications in patients with intracerebral hemorrhage (ICH), exploring how these complications relate to the stroke-heart syndrome, an under-researched area.
- Using data from a large international stroke trial database, researchers analyzed cardiac events occurring within 30 days after ICH or acute ischemic stroke (AIS), such as heart failure and arrhythmias.
- Results showed that while ICH patients had a lower overall rate of cardiac events compared to those with AIS, the incidence of certain complications, particularly atrial fibrillation, was significantly reduced in the ICH group.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!